Blue Moon Group Holdings Ltd
OTC:BLUMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Blue Moon Group Holdings Ltd
OTC:BLUMY
|
CN |
|
P
|
Procter & Gamble Co
XMUN:PRG
|
US |
|
A
|
Abbott Laboratories
SGO:ABT
|
US |
|
GomSpace Group AB
F:1G2
|
SE |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
Global Education Communities Corp
F:O3V
|
CA |
|
F
|
Fresenius SE & Co KGaA
OTC:FSNUF
|
DE |
|
Alnylam Pharmaceuticals Inc
LSE:0HD2
|
US |
|
W
|
Woolworths Group Ltd
XMUN:WWR
|
AU |
|
ByggPartner Gruppen AB (publ)
F:H05
|
SE |
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
Carnival Corp
NYSE:CCL
|
US |
|
Ferrovial SE
AEX:FER
|
NL |
|
W
|
Whirlpool Corp
BMV:WHR
|
US |
Wall St Price Targets
BLUMY Price Targets Summary
Blue Moon Group Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
BLUMY is 1.004 USD with a low forecast of 0.994 USD and a high forecast of 1.034 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BLUMY's stock price target?
Price Target
1.004
USD
According to Wall Street analysts, the average 1-year price target for
BLUMY is 1.004 USD with a low forecast of 0.994 USD and a high forecast of 1.034 USD.
What is the Revenue forecast for Blue Moon Group Holdings Ltd?
Projected CAGR
6%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 6%.